Michael Barbella, Managing Editor01.18.24
Catawba Research has realigned its to leadership. Former Chief Operating Officer Andrew Silverman, Ph.D., has been promoted to CEO and company Founder Zaidoon A. Al-Zubaidy is now executive chairman, enabling him to support customer relationships and mentor the executive leadership team.
Silverman was recruited to Catawba by Liberty Lane Partners due to his extensive background in clinical research built off a 30-year career with PPD, INC Research, and Syneos Health. “Since joining the firm in early 2022, Andy has exceeded our expectations at every step. He has been instrumental in establishing market-leading operational capabilities at Catawba that have positioned the company for its next phase of growth. His leadership has made an impact on all stakeholders and given us confidence that he will succeed in his expanded role,” Liberty Lane Partners Managing Director Nick Goldstein said.
“I am honored to be appointed CEO of Catawba Research,” Silverman stated. “Building on the foundation that Zaidoon and our team have established, we will continue our mission to drive innovation in clinical research and deliver agile solutions across an evolving portfolio of therapeutic areas to our clients and partners.”
As executive chairman, Al-Zubaidy will ensure Catawba remains dedicated to its core values as it grows. “I am proud of Catawba Research’s accomplishments since our founding in 2014. And I look forward to serving as a mentor and partner to our executive team as we pursue our next leg of growth,” he said. “While I’ll be stepping away from day-to-day operations, I will make sure Catawba remains an agile, responsive and trusted partner to our sponsors. I am extremely confident with Andy’s leadership and vision, we will continue our history of delivering excellence in clinical research services.”
Catawba Research is a contract research organization specializing in clinical research and development services for the pharmaceutical, biotechnology, and medical device industries. With a strong commitment to quality, innovation, and client satisfaction, Catawba Research delivers solutions to advance healthcare products from concept to market.
Silverman was recruited to Catawba by Liberty Lane Partners due to his extensive background in clinical research built off a 30-year career with PPD, INC Research, and Syneos Health. “Since joining the firm in early 2022, Andy has exceeded our expectations at every step. He has been instrumental in establishing market-leading operational capabilities at Catawba that have positioned the company for its next phase of growth. His leadership has made an impact on all stakeholders and given us confidence that he will succeed in his expanded role,” Liberty Lane Partners Managing Director Nick Goldstein said.
“I am honored to be appointed CEO of Catawba Research,” Silverman stated. “Building on the foundation that Zaidoon and our team have established, we will continue our mission to drive innovation in clinical research and deliver agile solutions across an evolving portfolio of therapeutic areas to our clients and partners.”
As executive chairman, Al-Zubaidy will ensure Catawba remains dedicated to its core values as it grows. “I am proud of Catawba Research’s accomplishments since our founding in 2014. And I look forward to serving as a mentor and partner to our executive team as we pursue our next leg of growth,” he said. “While I’ll be stepping away from day-to-day operations, I will make sure Catawba remains an agile, responsive and trusted partner to our sponsors. I am extremely confident with Andy’s leadership and vision, we will continue our history of delivering excellence in clinical research services.”
Catawba Research is a contract research organization specializing in clinical research and development services for the pharmaceutical, biotechnology, and medical device industries. With a strong commitment to quality, innovation, and client satisfaction, Catawba Research delivers solutions to advance healthcare products from concept to market.